Clinical, Patient-Reported, and Ultrasound Outcomes from an Open-Label, 12-week Observational Study of Certolizumab Pegol in Spanish Patients with Rheumatoid Arthritis with or without Prior Anti-TNF Exposure Francisco J. Blanco; Esteban Rubio-Romero; Raimon Sanmartí; César Díaz-Torné; Pablo Talavera; Jochen Dunkel; Esperanza Naredo;

Association between hypothyroidism and elderly-onset rheumatoid arthritis: A cross-sectional study at national hospital in Peru Paul J. Tejada-Llacsa; Vidia Lumbe Diaz; Carlos Diaz-Arocutipa;

Survival of first line biological and targeted synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis in Chile Marcos Cruces Olivar; Allan D. Burboa; Yolanda M. Gómez;